Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.5555
-0.1145 (-17.09%)
At close: Jul 17, 2026, 4:00 PM EDT
0.5700
+0.0145 (2.61%)
After-hours: Jul 17, 2026, 7:31 PM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $22.69 million as of July 17, 2026. Its market cap has decreased by -60.39% in one year.
Market Cap
22.69M
Enterprise Value
-32.16M
1-Year Change
-60.39%
Ranking
Category
Stock Price
$0.56
ChartMarket Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $22.69M, a decrease of -96.08%. That is a compound annual growth rate of -46.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 22.69M | -20.62% |
| Dec 31, 2025 | 28.59M | -41.18% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 25.12M |
| Jasper Therapeutics | 24.78M |
| NeuroSense Therapeutics | 24.18M |
| Skye Bioscience | 22.82M |
| Celularity | 22.59M |
| NewcelX | 22.02M |
| Marker Therapeutics | 21.84M |
| NextCure | 21.64M |